Health

MaxCyte Signs Platform License Agreement with Adicet Bio

August 04, 2025 08:05 ET  | Source: MaxCyte, Inc MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support development of…

5 months ago

Full Alliance Group Launches QUBEE HIVE HOLDINGS to Advance Global Web3 Financial Infrastructure

TAMPA, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) today announced the formation of QUBEE…

5 months ago

RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors

August 04, 2025 08:05 ET  | Source: RxSight, Inc. ALISO VIEJO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) –…

5 months ago

ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 01, 2025 16:15 ET  | Source: ImageneBio, Inc. SAN DIEGO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq:…

5 months ago

Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 01, 2025 16:08 ET  | Source: Protara Therapeutics NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc.…

5 months ago

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 01, 2025 16:05 ET  | Source: Akebia Therapeutics, Inc. CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®,…

5 months ago

Financire de Tubize – 2025 half-year financial report

August 02, 2025 02:00 ET  | Source: Financière de Tubize SA Half-year financial report 2025Regulated information 2 August 2025 The…

5 months ago

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 01, 2025 16:30 ET  | Source: Xilio Therapeutics, Inc. WALTHAM, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics,…

5 months ago

Sirona Biochem Update to Shareholders on Financial Status and Operations

August 01, 2025 16:30 ET  | Source: Sirona Biochem Corp. VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Sirona…

5 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

August 01, 2025 17:06 ET  | Source: Taysha Gene Therapies, Inc. DALLAS, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Taysha Gene…

5 months ago